Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015

Enihomo Obadan-Udoh, Nicoleta Lupulescu-Mann, Christina J. Charlesworth, Ulrike Muench, Matthew Jura, Hyunjee Kim, Eli Schwarz, Elizabeth Mertz, Benjamin Sun

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Dentists contribute to the prevailing opioid epidemic in the United States. Concerning the population enrolled in Medicaid, little is known about dentists’ opioid prescribing. Methods: The authors performed a retrospective cohort study of beneficiaries of Medicaid in Washington state with dental claims in 2014 and 2015. The primary outcome was the proportion of dental visits associated with an opioid prescription. The authors categorized visits as invasive or noninvasive by using procedure codes and each beneficiary as being at low or high risk by using his or her prescription history from the prescription drug monitoring program. Results: A total of 126,660 (10.3%) of all dental visits, most of which were invasive (66.9%), among the population enrolled in Medicaid in Washington state was associated with opioid prescriptions. However, noninvasive dental visits and visits for beneficiaries who had prior high-risk prescription use were associated with significantly higher mean days’ supply and mean quantity of opioids prescribed. Results from the multivariate logistic regression showed that the probability of having an opioid-associated visit increased by 35.6 percentage points when the procedures were invasive and by 11.1 percentage points when the beneficiary had prior high-risk prescription use. Conclusions: This baseline of opioid prescribing patterns after dental visits among the population enrolled in Medicaid in Washington state in 2014 and 2015 can inform future studies in which the investigators examine the effect of policies on opioid prescribing patterns and reasons for the variability in the dosage and duration of opioid prescriptions associated with noninvasive visits. Practical Implications: Dentists must exercise caution when prescribing opioids during invasive visits and to patients with prior high-risk prescription use.

Original languageEnglish (US)
Pages (from-to)259-268.e1
JournalJournal of the American Dental Association
Volume150
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Medicaid
Opioid Analgesics
Tooth
Prescriptions
Dentists
Population
Prescription Drugs
Drug Monitoring
Cohort Studies
Retrospective Studies
Logistic Models
History
Research Personnel
Exercise

Keywords

  • opioids
  • Oral health care
  • prescription drug monitoring programs
  • public insurance
  • Schedule II substances

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015. / Obadan-Udoh, Enihomo; Lupulescu-Mann, Nicoleta; Charlesworth, Christina J.; Muench, Ulrike; Jura, Matthew; Kim, Hyunjee; Schwarz, Eli; Mertz, Elizabeth; Sun, Benjamin.

In: Journal of the American Dental Association, Vol. 150, No. 4, 01.04.2019, p. 259-268.e1.

Research output: Contribution to journalArticle

Obadan-Udoh, Enihomo ; Lupulescu-Mann, Nicoleta ; Charlesworth, Christina J. ; Muench, Ulrike ; Jura, Matthew ; Kim, Hyunjee ; Schwarz, Eli ; Mertz, Elizabeth ; Sun, Benjamin. / Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015. In: Journal of the American Dental Association. 2019 ; Vol. 150, No. 4. pp. 259-268.e1.
@article{d4cd134c08c3459eaf22025775a7d408,
title = "Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015",
abstract = "Background: Dentists contribute to the prevailing opioid epidemic in the United States. Concerning the population enrolled in Medicaid, little is known about dentists’ opioid prescribing. Methods: The authors performed a retrospective cohort study of beneficiaries of Medicaid in Washington state with dental claims in 2014 and 2015. The primary outcome was the proportion of dental visits associated with an opioid prescription. The authors categorized visits as invasive or noninvasive by using procedure codes and each beneficiary as being at low or high risk by using his or her prescription history from the prescription drug monitoring program. Results: A total of 126,660 (10.3{\%}) of all dental visits, most of which were invasive (66.9{\%}), among the population enrolled in Medicaid in Washington state was associated with opioid prescriptions. However, noninvasive dental visits and visits for beneficiaries who had prior high-risk prescription use were associated with significantly higher mean days’ supply and mean quantity of opioids prescribed. Results from the multivariate logistic regression showed that the probability of having an opioid-associated visit increased by 35.6 percentage points when the procedures were invasive and by 11.1 percentage points when the beneficiary had prior high-risk prescription use. Conclusions: This baseline of opioid prescribing patterns after dental visits among the population enrolled in Medicaid in Washington state in 2014 and 2015 can inform future studies in which the investigators examine the effect of policies on opioid prescribing patterns and reasons for the variability in the dosage and duration of opioid prescriptions associated with noninvasive visits. Practical Implications: Dentists must exercise caution when prescribing opioids during invasive visits and to patients with prior high-risk prescription use.",
keywords = "opioids, Oral health care, prescription drug monitoring programs, public insurance, Schedule II substances",
author = "Enihomo Obadan-Udoh and Nicoleta Lupulescu-Mann and Charlesworth, {Christina J.} and Ulrike Muench and Matthew Jura and Hyunjee Kim and Eli Schwarz and Elizabeth Mertz and Benjamin Sun",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.adaj.2018.12.030",
language = "English (US)",
volume = "150",
pages = "259--268.e1",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "4",

}

TY - JOUR

T1 - Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015

AU - Obadan-Udoh, Enihomo

AU - Lupulescu-Mann, Nicoleta

AU - Charlesworth, Christina J.

AU - Muench, Ulrike

AU - Jura, Matthew

AU - Kim, Hyunjee

AU - Schwarz, Eli

AU - Mertz, Elizabeth

AU - Sun, Benjamin

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background: Dentists contribute to the prevailing opioid epidemic in the United States. Concerning the population enrolled in Medicaid, little is known about dentists’ opioid prescribing. Methods: The authors performed a retrospective cohort study of beneficiaries of Medicaid in Washington state with dental claims in 2014 and 2015. The primary outcome was the proportion of dental visits associated with an opioid prescription. The authors categorized visits as invasive or noninvasive by using procedure codes and each beneficiary as being at low or high risk by using his or her prescription history from the prescription drug monitoring program. Results: A total of 126,660 (10.3%) of all dental visits, most of which were invasive (66.9%), among the population enrolled in Medicaid in Washington state was associated with opioid prescriptions. However, noninvasive dental visits and visits for beneficiaries who had prior high-risk prescription use were associated with significantly higher mean days’ supply and mean quantity of opioids prescribed. Results from the multivariate logistic regression showed that the probability of having an opioid-associated visit increased by 35.6 percentage points when the procedures were invasive and by 11.1 percentage points when the beneficiary had prior high-risk prescription use. Conclusions: This baseline of opioid prescribing patterns after dental visits among the population enrolled in Medicaid in Washington state in 2014 and 2015 can inform future studies in which the investigators examine the effect of policies on opioid prescribing patterns and reasons for the variability in the dosage and duration of opioid prescriptions associated with noninvasive visits. Practical Implications: Dentists must exercise caution when prescribing opioids during invasive visits and to patients with prior high-risk prescription use.

AB - Background: Dentists contribute to the prevailing opioid epidemic in the United States. Concerning the population enrolled in Medicaid, little is known about dentists’ opioid prescribing. Methods: The authors performed a retrospective cohort study of beneficiaries of Medicaid in Washington state with dental claims in 2014 and 2015. The primary outcome was the proportion of dental visits associated with an opioid prescription. The authors categorized visits as invasive or noninvasive by using procedure codes and each beneficiary as being at low or high risk by using his or her prescription history from the prescription drug monitoring program. Results: A total of 126,660 (10.3%) of all dental visits, most of which were invasive (66.9%), among the population enrolled in Medicaid in Washington state was associated with opioid prescriptions. However, noninvasive dental visits and visits for beneficiaries who had prior high-risk prescription use were associated with significantly higher mean days’ supply and mean quantity of opioids prescribed. Results from the multivariate logistic regression showed that the probability of having an opioid-associated visit increased by 35.6 percentage points when the procedures were invasive and by 11.1 percentage points when the beneficiary had prior high-risk prescription use. Conclusions: This baseline of opioid prescribing patterns after dental visits among the population enrolled in Medicaid in Washington state in 2014 and 2015 can inform future studies in which the investigators examine the effect of policies on opioid prescribing patterns and reasons for the variability in the dosage and duration of opioid prescriptions associated with noninvasive visits. Practical Implications: Dentists must exercise caution when prescribing opioids during invasive visits and to patients with prior high-risk prescription use.

KW - opioids

KW - Oral health care

KW - prescription drug monitoring programs

KW - public insurance

KW - Schedule II substances

UR - http://www.scopus.com/inward/record.url?scp=85062991092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062991092&partnerID=8YFLogxK

U2 - 10.1016/j.adaj.2018.12.030

DO - 10.1016/j.adaj.2018.12.030

M3 - Article

C2 - 30922457

AN - SCOPUS:85062991092

VL - 150

SP - 259-268.e1

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 4

ER -